Vivaldi Biosciences

Developing influenza vaccines for seasonal and pandemic influenza

placeFort Collins, Colorado, United States calendar_todayFounded 2006 groups3 employees language vivaldibiosciences.com

Registered entities

Innovation

3 patent families (2 granted) — focus: Human necessities; filing pace slowing. Cited 140 times.

YearFilings
20201
20212
20222
20231
20252

Social engagement

Social engagement: 853 social following, 6 posts in the last 12 months — top quartile of its industry.

Investor mix

5 investors on record; lead investors include Bay City Capital, NGN Capital.

Investor typeCountShare
Venture capital360%
Other / undisclosed240%

Recent activity

9 Jan 2026
Partnership
FLUniversal consortium
19 Nov 2025
Recognition
5 Nov 2025
Milestone
regulatory
Coming soon